(Q36589376)

15 August 2017

1 reference

title

CPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channels (English)

1 reference

15 August 2017

De-Zai Dai

1

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Cardiovascular Drug Reviews

15 August 2017

published in

1 reference

15 August 2017

volume

24

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

101-115

1 reference

Brugada syndrome precipitated by a tricyclic antidepressant

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Molecular mechanisms underlying the long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Genetic profiling as a marker for risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Is there a future for antiarrhythmic drug therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Potassium channel down-regulation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

A decade of discoveries in cardiac biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Mechanisms of sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Management of long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

What causes sudden death in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Current treatment recommendations in antiarrhythmic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Defective cardiac ryanodine receptor regulation during atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

gamma-Glutamyl transpeptidase and l-cysteine regulate methylmercury uptake by HepG2 cells, a human hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Ryanodine receptor-targeted anti-arrhythmic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

Sudden unexplained death caused by cardiac ryanodine receptor (RyR2) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3466.2006.00101.X

10.1111/J.1527-3466.2006.00101.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference